| 标题 |
Concentration–Response Modeling of ECG Data From Early‐Phase Clinical Studies as an Alternative Clinical and Regulatory Approach to Assessing QT Risk — Experience From the Development Program of Lemborexant |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of clinical pharmacology 作者:Patricia Murphy; S. Yasuda; K. Nakai; T. Yoshinaga; N. Hall; et al 出版日期:2017-01-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)